Luis Barbeito
search externally: | Google Scholar, Springer, CiteSeer, Microsoft Academic Search, Scirus , DBlife |
Lectures:
keynote Masitinib as an add-on therapy to riluzole is beneficial in the treatment of amyotrophic lateral sclerosis (ALS) with acceptable tolerability: Results from a randomized controlled phase 3 trial as author at European Network to Cure ALS (ENCALS), Ljubljana 2017, together with: Olivier Hermine, Jesús S. Mora, 3005 views |
keynote Masitinib for the treatment of amyotrophic lateral sclerosis (ALS): preclinical overview as author at European Network to Cure ALS (ENCALS), Ljubljana 2017, 1022 views |
|||||||